Clinical Trial Details

A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease

Categories (click each to see list of all clinical trials associated with that category): Brain/Neuro (ONC), Breast (ONC), GI (ONC), Head & Neck (ONC), Radiation Oncology (RADONC), Thoracic (ONC)

Current Status: Open

Phase: II (Cancer Control)

Principal Investigator: Aizenberg-Ansari, Michele

Contact Information:
Susan Blumel, RN
402-559-9183
sblumel@unmc.edu

Eligibility: https://clinicaltrials.gov/study/NCT04222062?term=NCT04222062&rank=1

Summary
The primary outcome is to evaluate the efficacy of GLIADEL local chemotherapy compared to Stereotactic Radiosurgery (SRS) in preventing local recurrence after resection of a metastatic brain tumor (local recurrence at surgical site).